Tissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases

Breast Cancer Research and Treatment

Volumn 94, Issue 2, 2005, Pages 185-193

  Porter, Joseph F ^a   Sharma, Shashi ^b   Wilson, Donna L ^c   Kappil, Maya A ^a   Hart, Ronald P ^a,c   Denhardt, David T ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Cell metabolism; Metalloproteinase inhibitor; Microarray analysis; Sheddase

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; ENZYME INHIBITION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OVULATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SURFACE PROPERTY; WOUND HEALING;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METALLOPROTEASES; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 27544486640     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-7728-4     Document Type: Article

References (55)

1. K Brew D Dinakarpandian H Nagase 2000 Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 267 283
2. AH Baker DR Edwards G Murphy 2002 Metalloproteinase inhibitors: biological actions and therapeutic opportunities J Cell Sci 115 3719 3727
3. I Yana M Seiki 2002 MT-MMPs play pivotal roles in cancer dissemination Clin Exp Metastasis 19 209 215
4. MJ Duffy DJ Lynn AT Lloyd CM O'Shea 2003 The ADAMs family of proteins: from basic studies to potential clinical applications Thromb Haemost 89 622 631
5. L Nakopoulou I Giannopoulou AC Lazaris P Alexandrou I Tsirmpa S Markaki E Panayotopoulou A Keramopoulos 2003 The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells APMIS 111 1027 1036
6. KM Fong Y Kida PV Zimmerman PJ Smith 1996 TIMP1 and adverse prognosis in non-small cell lung cancer Clin Cancer Res 2 1369 1372
7. AH Ree VA Florenes JP Berg GM Maelandsmo JM Nesland O Fodstad 1997 High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases Clin Cancer Res 3 1623 1628
8. K [tmp] McCarthy T Maguire G [tmp] McGreal E [tmp] McDermott N O'Higgins MJ Duffy 1999 High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer Int J Cancer 84 44 48
9. L Nakopoulou I Giannopoulou K Stefanaki E Panayotopoulou I Tsirmpa P Alexandrou J Mavrommatis S Katsarou P Davaris 2002 Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis J Pathol 197 307 313
10. AS Schrohl IJ Christensen AN Pedersen V Jensen H Mouridsen G Murphy JA Foekens N Brunner MN Holten-Andersen 2003 Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer Mol Cell Proteomics 2 164 172
11. AS Schrohl MN Holten-Andersen HA Peters MP Look ME Meijer-van Gelder JG Klijn N Brunner JA Foekens 2004 Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer Clin Cancer Res 10 289 298
12. A Talvensaari-Mattila T Turpeenniemi-Hujanen 2005 High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma Breast Cancer Res Treat 89 29 34
13. Denhardt DT: On the paradoxical ability of TIMPs either to inhibit or to promote the development and progression of themalignant phenotype. In: Hawkes SP, Edwards DR, Khokha R (eds) Tissue Inhibitors of Metalloproteinases in Development and Disease. Harwood Academic Publishers, 2000, pp 137-151
14. MS de Lorenzo GV Ripoll H Yoshiji M Yamazaki UP Thorgeirsson DF Alonso DE Gomez 2003 Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1 In Vivo 17 45 50
15. JF Porter S Shen DT Denhardt 2004 Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinases Br J Cancer 90 463 470
16. T Hayakawa K Yamashita K Tanzawa E Uchijima K Iwata 1992 Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells; a possible new growth factor in serum FEBS Lett 298 29 32
17. C Luparello G Avancato C Carella I Pucci-Minafra 1999 Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells Breast Cancer Res Treat 54 235 244
18. K Yamashita M Suzuki H Iwata T Koike M Hamaguchi A Shinagawa T Noguchi T Hayakawa 1996 Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) FEBS Lett 396 103 107
19. T Wang K Yamashita K Iwata T Hayakawa 2002 Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways Biochem Biophys Res Commun 296 201 205
20. F Mannello G Gazzanelli 2001 Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications Apoptosis 6 479 482
21. SJ Lee HJ Yoo YS Bae HJ Kim ST Lee 2003 TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src Biochem Biophys Res Commun 312 1196 1201
22. G Li R Fridman HR Kim 1999 Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells Cancer Res 59 6267 6275
23. XW Liu MM Bernardo R Fridman HR Kim 2003 Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/ phosphatidylinositol 3-kinase and MAPK signaling pathway J Biol Chem 278 40364 40372
24. R Khokha P Waterhouse S Yagel PK Lala CM Overall G Norton DT Denhardt 1989 Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells Science 243 947 950
25. H Yoshiji SR Harris E Raso DE Gomez CK Lindsay M Shibuya CC Sinha UP Thorgeirsson 1998 Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression Int J Cancer 75 81 87
26. S Sellappan R Grijalva X Zhou W Yang MB Eli GB Mills D Yu 2004 Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line Cancer Res 64 3479 3485
27. NM Hooper EH Karran AJ Turner 1997 Membrane protein secretases Biochem J 321 265 279
28. F Kheradmand Z Werb 2002 Shedding light on sheddases: role in growth and development Bioessays 24 8 12
29. AM Dudley J Aach MA Steffen GM Church 2002 Measuring absolute expression with microarrays with a calibrated reference sample and an extended signal intensity range Proc Natl Acad Sci USA 99 7554 7559
30. JB Carmel O Kakinohana R Mestril W Young M Marsala RP Hart 2004 Mediators of ischemic preconditioning identified by microarray analysis of rat spinal cord Exp Neurol 185 81 96
31. BR Avalos SE Kaufman M Tomonaga RE Williams DW Golde JC Gasson 1988 K562 cells produce and respond to human erythroid-potentiating activity Blood 71 1720 1725
32. B Bertaux W Hornebeck AZ Eisen L Dubertret 1991 Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases J Invest Dermatol 97 679 685
33. L Chesler DW Golde N Bersch MD Johnson 1995 Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1 Blood 86 4506 4515
34. T Akahane M Akahane A Shah CM Connor UP Thorgeirsson 2004 TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms Exp Cell Res 301 158 167
35. T Akahane M Akahane A Shah UP Thorgeirsson 2004 TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways Biochem Biophys Res Commun 324 440 445
36. MH Lee K Maskos V Knauper P Dodds G Murphy 2002 Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: a new frontier in TIMP engineering Protein Sci 11 2493 2503
37. R Lang M Braun NE Sounni A Noel F Frankenne JM Foidart W Bode K Maskos 2004 Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features J Mol Biol 336 213 225
38. H Kolkenbrock L Essers N Ulbrich H Will 1999 Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinases Biol Chem 380 1103 1108
39. WR English G Velasco JO Stracke V Knauper G Murphy 2001 Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25) FEBS Lett 491 137 142
40. JM White 2003 ADAMs: modulators of cell-cell and cell-matrix interactions Curr Opin Cell Biol 15 598 606
41. A Amour CG Knight A Webster PM Slocombe PE Stephens V Knauper AJ Docherty G Murphy 2000 The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3 FEBS Lett 473 275 279
42. CW Franzke K Tasanen H Schacke Z Zhou K Tryggvason C Mauch P Zigrino S Sunnarborg DC Lee F Fahrenholz L Bruckner-Tuderman 2002 Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs EMBO J 21 5026 5035
43. J Codony-Servat J Albanell JC Lopez-Talavera J Arribas J Baselga 1999 Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells Cancer Res 59 1196 1201
44. H Lemjabbar C Basbaum 2002 Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells Nat Med 8 41 46
45. Y Yan K Shirakabe Z Werb 2002 The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors J Cell Biol 158 221 226
46. ML Moss MH Lambert 2002 Shedding of membrane proteins by ADAM family proteases Essays Biochem 38 141 153
47. U Sahin G Weskamp K Kelly HM Zhou S Higashiyama J Peschon D Hartmann P Saftig CP Blobel 2004 Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands J Cell Biol 164 769 779
48. CA Lunn X Fan B Dalie K Miller PJ Zavodny SK Narula D Lundell 1997 Purification of ADAM 10 from bovine spleen as a TNFalpha convertase FEBS Lett 400 333 335
49. WH Shen JH Zhou SR Broussard GG Freund R Dantzer KW Kelley 2002 Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor Cancer Res 62 4746 4756
50. WH Shen Y Yin SR Broussard RH [tmp] McCusker GG Freund R Dantzer KW Kelley 2004 Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis J Biol Chem 279 7438 7446
51. T Tanaka K Tanaka S Ogawa M Kurokawa K Mitani Y Yazaki Y Shibata H Hirai 1997 An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms Leukemia 11 Suppl 3 299 302
52. JM Smith PA Koopman 2004 The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease Trends Genet 20 4 8
53. J Chu EH Bresnick 2004 Evidence that C promoter-binding factor 1 binding is required for Notch-1-mediated repression of activator protein-1 J Biol Chem 279 12337 12345
54. T Mizutani Y Taniguchi T Aoki N Hashimoto T Honjo 2001 Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members Proc Natl Acad Sci USA 98 9026 9031
55. Porter JF: Characterization of the metabolic stimulation caused by tissue inhibitor of metalloproteinases-1 on human breast cancer cells. Doctoral Dissertation, Rutgers University, 2004